Russell Investments »

Aeglea Biotherapeutics shares owned by Russell Investments

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Russell Investments from 13F filings

Historical chart of Russell Investments investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Russell Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Russell Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $71k 4.2k 16.76
2025-06-30 $2.1k 142 14.97
2024-09-30 $3.8k 129 29.41

More positions owned by Russell Investments

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Meta Platforms Common Stock (META)
Alphabet Common Stock (GOOGL)
Alphabet Common Stock (GOOG)
Broadcom Common Stock (AVGO)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Mastercard Incorporated Common Stock (MA)
Tesla Common Stock (TSLA)
Welltower Common Stock (WELL)
J P Morgan Chase And Common Stock (JPM)
Visa Common Stock (V)
Oracle Corp Common Stock (ORCL)

View all positions for Russell Investments

Top funds holding Aeglea Biotherapeutics

FMR
Fairmount Funds Management
BlackRock
Rtw Investments
Tang Capital Management
Vanguard Group
VR Adviser
Braidwell
Capital Research and Management Company - Division 3
Driehaus Capital Management
Commodore Capital
State Street Corporation
Wellington Management Company
Paradigm Biocapital Advisors
Affinity Asset Advisors

View all funds holding Aeglea Biotherapeutics